Unsupervised Hybrid framework for ANomaly Detection (HAND) -- applied to Screening Mammogram
This provides an incremental solution for automated quality checks in external screening mammograms, addressing domain-specific challenges in medical imaging without accessing private data.
The paper tackled the problem of out-of-distribution detection in mammogram screening by developing an unsupervised hybrid framework (HAND) that uses synthetic OOD samples and a discriminator to improve detection, achieving superior performance over baselines on internal and external datasets.
Out-of-distribution (OOD) detection is crucial for enhancing the generalization of AI models used in mammogram screening. Given the challenge of limited prior knowledge about OOD samples in external datasets, unsupervised generative learning is a preferable solution which trains the model to discern the normal characteristics of in-distribution (ID) data. The hypothesis is that during inference, the model aims to reconstruct ID samples accurately, while OOD samples exhibit poorer reconstruction due to their divergence from normality. Inspired by state-of-the-art (SOTA) hybrid architectures combining CNNs and transformers, we developed a novel backbone - HAND, for detecting OOD from large-scale digital screening mammogram studies. To boost the learning efficiency, we incorporated synthetic OOD samples and a parallel discriminator in the latent space to distinguish between ID and OOD samples. Gradient reversal to the OOD reconstruction loss penalizes the model for learning OOD reconstructions. An anomaly score is computed by weighting the reconstruction and discriminator loss. On internal RSNA mammogram held-out test and external Mayo clinic hand-curated dataset, the proposed HAND model outperformed encoder-based and GAN-based baselines, and interestingly, it also outperformed the hybrid CNN+transformer baselines. Therefore, the proposed HAND pipeline offers an automated efficient computational solution for domain-specific quality checks in external screening mammograms, yielding actionable insights without direct exposure to the private medical imaging data.